Translational applications of evaluating physiologic variability in human endotoxemia

Journal of Clinical Monitoring and Computing

Volumn 27, Issue 4, 2013, Pages 405-415

  Scheff, Jeremy D ^a   Mavroudis, Panteleimon D ^b   Calvano, Steve E ^c   Androulakis, Ioannis P ^a,b,c  

^a RUTGERS UNIVERSITY   (United States)

^b The State University of New Jersey   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Circadian rhythms; Cortisol; Decomplexification; Heart rate variability; Systemic inflammation

Indexed keywords

BIOLOGICAL PROCESS; CIRCADIAN RHYTHMS; COMPUTATIONAL SYSTEMS BIOLOGY; DECOMPLEXIFICATION; HEART RATE VARIABILITY; INFLAMMATORY RESPONSE; INFORMATION CONTENTS; SYSTEMIC INFLAMMATION;

CORTISOL; HEART; PATHOLOGY; PATIENT REHABILITATION;

PHYSIOLOGY;

CYTOKINE ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR 4;

ARTICLE; AUTONOMIC NERVOUS SYSTEM; CHRONIC INFLAMMATION; CIRCADIAN RHYTHM; CONVALESCENCE; CYTOKINE RELEASE; DISEASE COURSE; ENDOTOXEMIA; ENTERITIS; HEART RATE VARIABILITY; HUMAN; MATHEMATICAL MODEL; NON INVASIVE MEASUREMENT; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEPSIS; SINUS NODE; SYMPATHETIC TONE; SYSTEMS BIOLOGY; ULTRADIAN RHYTHM;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; CIRCADIAN RHYTHM; ENDOTOXEMIA; HEART RATE; HOMEOSTASIS; HORMONES; HUMANS; HYDROCORTISONE; INFLAMMATION; LIPOPOLYSACCHARIDES; MODELS, THEORETICAL; SEPSIS; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84879553651     PISSN: 13871307     EISSN: 15732614     Source Type: Journal    
DOI: 10.1007/s10877-012-9418-1     Document Type: Article

References (115)

1. Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat Rev Immunol. 2008;8(10):776-87.
2. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through. N Engl J Med. 2003;348(16):1546-54.
3. Namas R, Zamora R, Namas R, An G, Doyle J, Dick TE, Jacono FJ, Androulakis IP, Nieman GF, Chang S, Billiar TR, Kellum JA, Angus DC, Vodovotz Y. Sepsis: something old, something new, and a systems view. J Crit Care. 2011;27(3):314 e1-11.
4. Novak B, Tyson JJ. Design principles of biochemical oscillators. Nat Rev Mol Cell Biol. 2008;9(12):981-91.
5. Pigolotti S, Krishna S, Jensen MH. Oscillation patterns in negative feedback loops. Proc Natl Acad Sci USA. 2007;104(16):6533-7.
6. Veldhuis JD, Keenan DM, Pincus SM. Motivations and methods for analyzing pulsatile hormone secretion. Endocr Rev. 2008;29(7):823-64.
7. Griffin MP, O'Shea TM, Bissonette EA, Harrell FE Jr, Lake DE, Moorman JR. Abnormal heart rate characteristics preceding neonatal sepsis and sepsis-like illness. Pediatr Res. 2003;53(6):920-6.
8. Moorman JR, Carlo WA, Kattwinkel J, Schelonka RL, Porcelli PJ, Navarrete CT, Bancalari E, Aschner JL, Whit Walker M, Perez JA, Palmer C, Stukenborg GJ, Lake DE, Michael O'Shea T. Mortality reduction by heart rate characteristic monitoring in very low birth weight neonates: a randomized trial. J Pediatr. 2011;159(6):900-6. (e901).
9. Yehuda R, Teicher MH, Trestman RL, Levengood RA, Siever LJ. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol Psychiatry. 1996;40(2):79-88.
10. Rosmond R, Dallman MF, Bjorntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab. 1998;83(6):1853-9.
11. Polk DE, Cohen S, Doyle WJ, Skoner DP, Kirschbaum C. State and trait affect as predictors of salivary cortisol in healthy adults. Psychoneuroendocrinology. 2005;30(3):261-72.
12. Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst. 2000;92(12):994-1000.
13. Mormont MC, Levi F. Circadian-system alterations during cancer processes: a review. Int J Cancer. 1997;70(2):241-7.
14. Lowry SF. Human endotoxemia: a model for mechanistic insight and therapeutic targeting. Shock. 2005;24(Suppl 1):94-100.
15. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. Modeling endotoxin-induced systemic inflammation using an indirect response approach. Math Biosci. 2009;217(1):27-42.
16. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. In silico simulation of corticosteroids effect on an NFkB- dependent physicochemical model of systemic inflammation. PLoS ONE. 2009;4(3):e4706.
17. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. Multiscale model for the assessment of autonomic dysfunction in human endotoxemia. Physiol Genomics. 2010;42(1):5-19.
18. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. A physiological model for autonomic heart rate regulation in human endotoxemia. Shock. 2011;35(3):229-39.
19. Dong X, Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. Agent-based modeling of endotoxin-induced acute inflammatory response in human blood leukocytes. PLoS ONE. 2010;5(2):e9249.
20. Scheff JD, Calvano SE, Lowry SF, Androulakis IP. Modeling the influence of circadian rhythms on the acute inflammatory response. J Theor Biol. 2010;264(3):1068-76.
21. Scheff JD, Mavroudis PD, Calvano SE, Lowry SF, Androulakis IP. Modeling autonomic regulation of cardiac function and heart rate variability in human endotoxemia. Physiol Genomics. 2011;43(16):951-64.
22. Rassias AJ, Holzberger PT, Givan AL, Fahrner SL, Yeager MP. Decreased physiologic variability as a generalized response to human endotoxemia. Crit Care Med. 2005;33(3):512-9.
23. Andreasen AS, Krabbe KS, Krogh-Madsen R, Taudorf S, Pedersen BK, Moller K. Human endotoxemia as a model of systemic inflammation. Curr Med Chem. 2008;15(17):1697-705.
24. Buttenschoen K, Kornmann M, Berger D, Leder G, Beger HG, Vasilescu C. Endotoxemia and endotoxin tolerance in patients with ARDS. Langenbecks Arch Surg. 2008;393(4):473-8.
25. Shanker BA, Coyle SM, Reddell MT, Choi CW, Calvano J, Macor MA, Calvano SE, Lowry SF Modeling the human injury response. J Am Coll Surg. 2010;211(3 Suppl 1):53-54.
26. Lowry SF. The stressed host response to infection: the disruptive signals and rhythms of systemic inflammation. Surg Clin North Am. 2009;89(2):311-26.
27. Deans KJ, Haley M, Natanson C, Eichacker PQ, Minneci PC. Novel therapies for sepsis: a review. J Trauma. 2005;58(4):867-74.
28. Marshall JC. Such stuff as dreams are made on: mediator-directed therapy in sepsis. Nat Rev Drug Discov. 2003;2(5):391-405.
29. Freeman BD, Natanson C. Anti-inflammatory therapies in sepsis and septic shock. Expert Opin Investig Drugs. 2000;9(7):1651-63.
30. Vodovotz Y, Constantine G, Rubin J, Csete M, Voit EO, An G. Mechanistic simulations of inflammation: current state and future prospects. Math Biosci. 2009;217(1):1-10.
31. Day J, Rubin J, Vodovotz Y, Chow CC, Reynolds A, Clermont G. A reduced mathematical model of the acute inflammatory response II. Capturing scenarios of repeated endotoxin administration. J Theor Biol. 2006;242(1):237-56.
32. Kumar R, Clermont G, Vodovotz Y, Chow CC. The dynamics of acute inflammation. J Theor Biol. 2004;230(2):145-55.
33. Reynolds A, Rubin J, Clermont G, Day J, Vodovotz Y, Bard Ermentrout G. A reduced mathematical model of the acute inflammatory response: I. Derivation of model and analysis of anti-inflammation. J Theor Biol. 2006;242(1):220-36.
34. Arciero JC, Ermentrout GB, Upperman JS, Vodovotz Y, Rubin JE. Using a mathematical model to analyze the role of probiotics and inflammation in necrotizing enterocolitis. PLoS ONE. 2010;5(4):e10066.
35. Riviere B, Epshteyn Y, Swigon D, Vodovotz Y. A simple mathematical model of signaling resulting from the binding of lipopolysaccharide with Toll-like receptor 4 demonstrates inherent preconditioning behavior. Math Biosci. 2009;217(1):19-26.
36. Nieman G, Brown D, Sarkar J, Kubiak B, Ziraldo C, Dutta-Moscato J, Vieau C, Barclay D, Gatto L, Maier K, Constantine G, Billiar TR, Zamora R, Mi Q, Chang S, Vodovotz Y. A two-compartment mathematical model of endotoxin-induced inflammatory and physiologic alterations in swine. Crit Care Med. 2012;40(4):1052-63.
37. Torres A, Bentley T, Bartels J, Sarkar J, Barclay D, Namas R, Constantine G, Zamora R, Puyana JC, Vodovotz Y. Mathematical modeling of posthemorrhage inflammation in mice: studies using a novel, computer-controlled, closed-loop hemorrhage apparatus. Shock. 2009;32(2):172-8.
38. Yang Q, Calvano SE, Lowry SF, Androulakis IP. A dual negative regulation model of Toll-like receptor 4 signaling for endotoxin preconditioning in human endotoxemia. Math Biosci. 2011;232(2):151-63.
39. Daun S, Rubin J, Vodovotz Y, Roy A, Parker R, Clermont G. An ensemble of models of the acute inflammatory response to bacterial lipopolysaccharide in rats: results from parameter space reduction. J Theor Biol. 2008;253(4):843-53.
40. Li NY, Vodovotz Y, Kim KH, Mi Q, Hebda PA, Abbott KV. Biosimulation of acute phonotrauma: an extended model. Laryngoscope. 2011;121(11):2418-28.
41. Brown BN, Price IM, Toapanta FR, DeAlmeida DR, Wiley CA, Ross TM, Oury TD, Vodovotz Y. An agent-based model of inflammation and fibrosis following particulate exposure in the lung. Math Biosci. 2011;231(2):186-96.
42. Li NY, Vodovotz Y, Hebda PA, Abbott KV. Biosimulation of inflammation and healing in surgically injured vocal folds. Ann Otol Rhinol Laryngol. 2010;119(6):412-23.
43. Li NY, Verdolini K, Clermont G, Mi Q, Rubinstein EN, Hebda PA, Vodovotz Y. A patient-specific in silico model of inflammation and healing tested in acute vocal fold injury. PLoS ONE. 2008;3(7):e2789.
44. Mi Q, Riviere B, Clermont G, Steed DL, Vodovotz Y. Agent-based model of inflammation and wound healing: insights into diabetic foot ulcer pathology and the role of transforming growth factor-beta1. Wound Repair Regen. 2007;15(5):671-82.
45. An G. In silico experiments of existing and hypothetical cytokine-directed clinical trials using agent-based modeling. Crit Care Med. 2004;32(10):2050-60.
46. An G. Introduction of an agent-based multi-scale modular architecture for dynamic knowledge representation of acute inflammation. Theor Biol Med Model. 2008;5:11.
47. An G, Mi Q, Dutta-Moscato J, Vodovotz Y. Agent-based models in translational systems biology. Wiley Interdiscip Rev Syst Biol Med. 2009;1(2):159-71.
48. Kim M, Christley S, Alverdy JC, Liu D, An G. Immature oxidative stress management as a unifying principle in the pathogenesis of necrotizing enterocolitis: insights from an agent-based model. Surg Infect (Larchmt). 2012;13(1):18-32.
49. Seal JB, Alverdy JC, Zaborina O, An G. Agent-based dynamic knowledge representation of Pseudomonas aeruginosa virulence activation in the stressed gut: towards characterizing host-pathogen interactions in gut-derived sepsis. Theor Biol Med Model. 2011;8:33.
50. Mi Q, Constantine G, Ziraldo C, Solovyev A, Torres A, Namas R, Bentley T, Billiar TR, Zamora R, Puyana JC, Vodovotz Y. A dynamic view of trauma/hemorrhage-induced inflammation in mice: principal drivers and networks. PLoS ONE. 2011;6(5):e19424.
51. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, Miller-Graziano C, Moldawer LL, Mindrinos MN, Davis RW, Tompkins RG, Lowry SF. A network-based analysis of systemic inflammation in humans. Nature. 2005;437(7061):1032-7.
52. Yang EH, Almon RR, Dubois DC, Jusko WJ, Androulakis IP. Identification of global transcriptional dynamics. PLoS ONE. 2009;4(7):e5992.
53. Aldridge BB, Burke JM, Lauffenburger DA, Sorger PK. Physicochemical modelling of cell signalling pathways. Nat Cell Biol. 2006;8(11):1195-203.
54. Webster JI, Tonelli L, Sternberg EM. Neuroendocrine regulation of immunity. Annu Rev Immunol. 2002;20:125-63.
55. Padgett DA, Glaser R. How stress influences the immune response. Trends Immunol. 2003;24(8):444-8.
56. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve-an integrative interface between two super systems: the brain and the immune system. Pharmacol Rev. 2000;52(4):595-638.
57. van der Poll T, Coyle SM, Barbosa K, Braxton CC, Lowry SF. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest. 1996;97(3):713-9.
58. van der Poll T. Effects of Catecholamines on the Inflammatory Response. Sepsis. 2000;4:159-67.
59. Pavlov VA, Wang H, Czura CJ, Friedman SG, Tracey KJ. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med. 2003;9(5-8):125-34.
60. Alvarez SM, Katsamanis Karavidas M, Coyle SM, Lu SE, Macor M, Oikawa LO, Lehrer PM, Calvano SE, Lowry SF. Low-dose steroid alters in vivo endotoxin-induced systemic inflammation but does not influence autonomic dysfunction. J Endotoxin Res. 2007;13(6):358-68.
61. van der Poll T, Barber AE, Coyle SM, Lowry SF. Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia-a clinical research center study. J Clin Endocrinol Metab. 1996;81(10):3604-6.
62. Jan BU, Coyle SM, Oikawa LO, Lu SE, Calvano SE, Lehrer PM, Lowry SF. Influence of acute epinephrine infusion on endotoxin-induced parameters of heart rate variability: a randomized controlled trial. Ann Surg. 2009;249(5):750-6.
63. Ramakrishnan R, DuBois DC, Almon RR, Pyszczynski NA, Jusko WJ. Fifth-generation model for corticosteroid pharmacodynamics: application to steady-state receptor down-regulation and enzyme induction patterns during seven-day continuous infusion of methylprednisolone in rats. J Pharmacokinet Pharmacodyn. 2002;29(1):1-24.
64. Coogan AN, Wyse CA. Neuroimmunology of the circadian clock. Brain Res. 2008;1232:104-12.
65. Haimovich B, Calvano J, Haimovich AD, Calvano SE, Coyle SM, Lowry SF. In vivo endotoxin synchronizes and suppresses clock gene expression in human peripheral blood leukocytes. Crit Care Med. 2010;38(3):751-8.
66. Pollmacher T, Mullington J, Korth C, Schreiber W, Hermann D, Orth A, Galanos C, Holsboer F. Diurnal variations in the human host response to endotoxin. J Infect Dis. 1996;174(5):1040-5.
67. Chakraborty A, Krzyzanski W, Jusko WJ. Mathematical modeling of circadian cortisol concentrations using indirect response models: comparison of several methods. J Pharmacokinet Biopharm. 1999;27(1):23-43.
68. Lightman SL, Conway-Campbell BL. The crucial role of pulsatile activity of the HPA axis for continuous dynamic equilibration. Nat Rev Neurosci. 2010;11(10):710-8.
69. McNally JG, Muller WG, Walker D, Wolford R, Hager GL. The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. Science. 2000;287(5456):1262-5.
70. Stavreva DA, Wiench M, John S, Conway-Campbell BL, McKenna MA, Pooley JR, Johnson TA, Voss TC, Lightman SL, Hager GL. Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription. Nat Cell Biol. 2009;11(9):1093-102.
71. McMaster A, Jangani M, Sommer P, Han N, Brass A, Beesley S, Lu W, Berry A, Loudon A, Donn R, Ray DW. Ultradian cortisol pulsatility encodes a distinct, biologically important signal. PLoS ONE. 2011;6(1):e15766.
72. Scheff JD, Kosmides AK, Calvano SE, Lowry SF, Androulakis IP. Pulsatile glucocorticoid secretion: origins and downstream effects. IEEE Trans Biomed Eng. 2011;58(12):3504-7.
73. Scheff JD, Calvano SE, Lowry SF, Androulakis IP. Transcriptional implications of ultradian glucocorticoid secretion in homeostasis and in the acute stress response. Physiol Genomics. 2012;44(2):121-9.
74. Schmidt HB, Werdan K, Muller-Werdan U. Autonomic dysfunction in the ICU patient. Curr Opin Crit Care. 2001;7(5):314-22.
75. Gholami M, Mazaheri P, Mohamadi A, Dehpour T, Safari F, Hajizadeh S, Moore KP, Mani AR. Endotoxemia is Associated With Partial Uncoupling of Cardiac Pacemaker From Cholinergic Neural Control in Rats. Shock. 2012;37(2):219-27.
76. Godin PJ, Fleisher LA, Eidsath A, Vandivier RW, Preas HL, Banks SM, Buchman TG, Suffredini AF. Experimental human endotoxemia increases cardiac regularity: results from a prospective, randomized, crossover trial. Crit Care Med. 1996;24(7):1117-24.
77. Rassias AJ, Guyre PM, Yeager MP. Hydrocortisone at stress-associated concentrations helps maintain human heart rate variability during subsequent endotoxin challenge. J Crit Care. 2011;26(6):636.e1-5.
78. Sayk F, Vietheer A, Schaaf B, Wellhoener P, Weitz G, Lehnert H, Dodt C. Endotoxemia causes central downregulation of sympathetic vasomotor tone in healthy humans. Am J Physiol Regul Integr Comp Physiol. 2008;295(3):R891-8.
79. Jan BU, Coyle SM, Macor MA, Reddell M, Calvano SE, Lowry SF. Relationship of basal heart rate variability to in vivo cytokine responses after endotoxin exposure. Shock. 2010;33(4):363-8.
80. Kox M, Ramakers BP, Pompe JC, van der Hoeven JG, Hoedemaekers CW, Pickkers P. Interplay between the acute inflammatory response and heart rate variability in healthy human volunteers. Shock. 2011;36(2):115-20.
81. Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science. 1981;213(4504):220-2. doi: 10.1126/science.6166045.
82. Task. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task force of the European society of cardiology and the North American society of pacing and electrophysiology. Circulation. 1996;93(5):1043-65.
83. Berntson GG, Bigger JT Jr, Eckberg DL, Grossman P, Kaufmann PG, Malik M, Nagaraja HN, Porges SW, Saul JP, Stone PH, van der Molen MW. Heart rate variability: origins, methods, and interpretive caveats. Psychophysiology. 1997;34(6):623-48.
84. deBoer RW, Karemaker JM, Strackee J. Hemodynamic fluctuations and baroreflex sensitivity in humans: a beat-to-beat model. Am J Physiol. 1987;253(3 Pt 2):H680-9.
85. Karemaker JM. Autonomic integration: the physiological basis of cardiovascular variability. J Physiol. 1999;517(Pt 2):316.
86. Dick TE, Molkov YI, Nieman G, Hsieh YH, Jacono FJ, Doyle J, Scheff JD, Calvano SE, Androulakis IP, An G, Vodovotz Y. Linking inflammation, cardiorespiratory variability, and neural control in acute inflammation via computational modeling. Front Physiol. 2012;3:222.
87. Boyett MR, Honjo H, Kodama I. The sinoatrial node, a heterogeneous pacemaker structure. Cardiovasc Res. 2000;47(4):658-87.
88. Stys A, Stys T. Current clinical applications of heart rate variability. Clin Cardiol. 1998;21(10):719-24.
89. Annane D, Trabold F, Sharshar T, Jarrin I, Blanc AS, Raphael JC, Gajdos P. Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach. Am J Respir Crit Care Med. 1999;160(2):458-65.
90. Eckberg DL. Sympathovagal balance: a critical appraisal. Circulation. 1997;96(9):3224-32.
91. Batchinsky AI, Skinner JE, Necsoiu C, Jordan BS, Weiss D, Cancio LC. New measures of heart-rate complexity: effect of chest trauma and hemorrhage. J Trauma. 2010;68(5):1178-85.
92. Cancio LC, Batchinsky AI, Salinas J, Kuusela T, Convertino VA, Wade CE, Holcomb JB. Heart-rate complexity for prediction of prehospital lifesaving interventions in trauma patients. J Trauma. 2008;65(4):813-9.
93. Morris JA Jr, Norris PR, Waitman LR, Ozdas A, Guillamondegui OD, Jenkins JM. Adrenal insufficiency, heart rate variability, and complex biologic systems: a study of 1, 871 critically ill trauma patients. J Am Coll Surg. 2007;204(5):885-92. (discussion 892-883).
94. Riordan WP Jr, Norris PR, Jenkins JM, Morris JA Jr. Early loss of heart rate complexity predicts mortality regardless of mechanism, anatomic location, or severity of injury in 2178 trauma patients. J Surg Res. 2009;156(2):283-9.
95. Ahmad S, Ramsay T, Huebsch L, Flanagan S, McDiarmid S, Batkin I, McIntyre L, Sundaresan SR, Maziak DE, Shamji FM, Hebert P, Fergusson D, Tinmouth A, Seely AJ. Continuous multi-parameter heart rate variability analysis heralds onset of sepsis in adults. PLoS ONE. 2009;4(8):e6642.
96. Fairchild KD, Srinivasan V, Moorman JR, Gaykema RP, Goehler LE. Pathogen-induced heart rate changes associated with cholinergic nervous system activation. Am J Physiol Regul Integr Comp Physiol. 2011;300(2):R330-9.
97. Huang J, Wang Y, Jiang D, Zhou J, Huang X. The sympathetic-vagal balance against endotoxemia. J Neural Transm. 2010;117(6):729-35.
98. Schmidt H, Saworski J, Werdan K, Muller-Werdan U. Decreased beating rate variability of spontaneously contracting cardiomyocytes after co-incubation with endotoxin. J Endotoxin Res. 2007;13(6):339-42.
99. Takayama K, Yuhki K, Ono K, Fujino T, Hara A, Yamada T, Kuriyama S, Karibe H, Okada Y, Takahata O, Taniguchi T, Iijima T, Iwasaki H, Narumiya S, Ushikubi F. Thromboxane A2 and prostaglandin F2alpha mediate inflammatory tachycardia. Nat Med. 2005;11(5):562-6.
100. Godin PJ, Buchman TG. Uncoupling of biological oscillators: a complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med. 1996;24(7):1107-16.
101. Pincus SM. Greater signal regularity may indicate increased system isolation. Math Biosci. 1994;122(2):161-81.
102. Lowry SF, Calvano SE. Challenges for modeling and interpreting the complex biology of severe injury and inflammation. J Leukoc Biol. 2008;83(3):553-7.
103. Tracey KJ. The inflammatory reflex. Nature. 2002;420(6917):853-9.
104. Huston JM, Gallowitsch-Puerta M, Ochani M, Ochani K, Yuan R, Rosas-Ballina M, Ashok M, Goldstein RS, Chavan S, Pavlov VA, Metz CN, Yang H, Czura CJ, Wang H, Tracey KJ. Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit Care Med. 2007;35(12):2762-8.
105. Balsalobre A, Brown SA, Marcacci L, Tronche F, Kellendonk C, Reichardt HM, Schutz G, Schibler U. Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science. 2000;289(5488):2344-7.
106. Hashiramoto A, Yamane T, Tsumiyama K, Yoshida K, Komai K, Yamada H, Yamazaki F, Doi M, Okamura H, Shiozawa S. Mammalian clock gene Cryptochrome regulates arthritis via proinflammatory cytokine TNF-alpha. J Immunol. 2010;184(3):1560-5.
107. Motzkus D, Albrecht U, Maronde E. The human PER1 gene is inducible by interleukin-6. J Mol Neurosci. 2002;18(1-2):105-9.
108. Levi F, Schibler U. Circadian rhythms: mechanisms and therapeutic implications. Annu Rev Pharmacol Toxicol. 2007;47:593-628.
109. Mavroudis PD, Scheff JD, Calvano SE, Lowry SF, Androulakis IP. Entrainment of peripheral clock genes by cortisol. Physiol Genomics. 2012;44(11):607-21.
110. Petrovsky N, Harrison LC. The chronobiology of human cytokine production. Int Rev Immunol. 1998;16(5-6):635-49.
111. Donadio V, Cortelli P, Falzone F, Bugiardini E, Giuliani A, Misciali C, Montagna P, Calza L, Liguori R. Isolated generalised anhidrosis induced by postganglionic sympathetic skin nerve fibre degeneration: an incomplete Ross syndrome? J Neurol Neurosurg Psychiatry. 2008;79(8):959-61.
112. Brown EN, Meehan PM, Dempster AP. A stochastic differential equation model of diurnal cortisol patterns. Am J Physiol Endocrinol Metab. 2001;280(3):E450-61.
113. Charloux A, Gronfier C, Lonsdorfer-Wolf E, Piquard F, Brandenberger G. Aldosterone release during the sleep-wake cycle in humans. Am J Physiol. 1999;276(1 Pt 1):E43-9.
114. Seydnejad SR, Kitney RI. Modeling of Mayer waves generation mechanisms. IEEE Eng Med Biol Mag. 2001;20(2):92-100.
115. Octavio JA, Rodriguez AE, Misticchio F, Marcano A, Jimenez J, Moleiro F. Circadian profiles of heart rate and its instantaneous variability in patients with chronic Chagas' disease. Rev Esp Cardiol. 2004;57(2):130-7.